Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, January 27, 2015
 
Register | Sign in
Home Page>Products
  Product News
Horizon Launches Gene-Engineered Bioproduction Cell Line
Tuesday, December 09, 2014
Precisely engineered cell line will facilitate a new revenue stream and enable faster, more efficient production of therapeutic antibodies.

Bruker Launches NanoForce Nanomechanical Testing System
Tuesday, December 09, 2014
Enabling true nanoindenting studies and imaging on a single platform.

Highly Versatile Single Tube Code Reader
Friday, December 05, 2014
The Tracxer TS201 MINI designed to enhance users lab space.

Fast GC Add-on for IONICON PTR-TOF Instruments
Friday, December 05, 2014
Gas Chromatographic separation now combined with real-time trace gas analysis.

BioTek Introduces Cytation™ 5 Cell Imager at ASCB 2014
Thursday, December 04, 2014
ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania.

Limited Time Sale from Bibby Scientific
Thursday, December 04, 2014
Web Shop offers savings of up to 15% on all laboratory equipment.

Rigaku Publishes New Application Report
Thursday, December 04, 2014
New application report for quality and process control of iron ore products by pressed powder method.

One Lambda's New RUO NXType Kit Available
Thursday, December 04, 2014
The new kit is a complete solution for HLA typing by NGS.

TGAC Understanding Life on Earth
Thursday, December 04, 2014
The Genome Analysis Centre (TGAC) uses Intel-powered super computers to collect and crunch complex data that is shaping the future of science.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 10834
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn